Most Recent Articles about JAZZ
Jazz's (JAZZ) New Sleep Drug Sunosi Gets Schedule IV Status http://www.zacks.com/stock/news/431105/jazzs-jazz-new-sleep-drug-sunosi-gets-schedule-iv-status?cid=CS-ZC-FT-431105 Jun 18, 2019 - Jazz Pharmaceuticals' (JAZZ) recently approved sleep drug, Sunosi, receives schedule IV designation under controlled substance list from the Drug Enforcement Agency.
Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock? http://www.zacks.com/stock/news/429604/should-value-investors-buy-jazz-pharmaceuticals-jazz-stock?cid=CS-ZC-FT-429604 Jun 14, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Boz Scaggs talks about his recent musical trilogy ahead of Playboy Jazz Festival appearance https://www.ocregister.com/2019/06/07/boz-scaggs-talks-about-his-recent-musical-trilogy-ahead-of-playboy-jazz-festival-appearance/ Jun 07, 2019 - The veteran singer talks about his recent albums ahead of his appearance at the Playboy Jazz Festival.

Related Companies

Name Exchange Price Mkt Cap
PRGO Perrigo Company NYSE $72.57 $9.93B
BGNE BeiGene, Ltd. NASDAQ $159.91 $9.47B
ALNY Alnylam Pharmaceuticals, Inc. NASDAQ $93.43 $9.41B
NKTR Nektar Therapeutics NASDAQ $58.29 $10.05B
SRPT Sarepta Therapeutics, Inc. NASDAQ $152.52 $10.13B
Sector: Health Care > Industry: Major Pharmaceuticals